| http://www.w3.org/ns/prov#value | - As of September 30, 2009 inventories had increased by $124,000 due to receipt of a recent raw material supply order and prepaid expenses and other current assets generated cash of $676,000 primarily related to collection of shared costs incurred under the Novartis agreement, payable by Novartis, in the amount of $425,000.Net cash consumed by operating activities was $3,959,000 during the nine mont
|
